Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Investi is a prominent Argentine pharmaceutical company and a key subsidiary of the Roemmers Group, one of the largest healthcare conglomerates in Latin America. The company specializes in the development, production, and commercialization of high-quality therapeutic products, with a market-leading position in women's health and gynecology. Beyond its core focus on hormonal therapies and contraceptives, Investi maintains a significant presence in oncology, neuropsychiatry, and urology. The company is recognized for its state-of-the-art manufacturing capabilities and its extensive portfolio of both proprietary branded generics and licensed international products. Investi plays a vital role in the Argentine healthcare system by providing accessible treatments for complex chronic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Investi.